INVO Bioscience (INVO) has released an update.
INVO Bioscience, Inc. entered into an agreement with NAYA Bioscience, Inc. for the sale of 1,000,000 shares of Series A Preferred Stock, with the purchase structured in tranches. However, NAYA did not meet the funding deadline for the second tranche, prompting INVO Bioscience to seek alternative funding sources to compensate for the missed payment, per the terms of their merger agreement.
For further insights into INVO stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
